HalioDx
Marseille
About HalioDx
HalioDx designs and develops diagnostic tests in oncology utilizing the immune contexture of cancers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $31.5M
- Funding stage: M&A
- Last round: Series B (Jan 2018)
- Website: haliodx.com
- Phone: +33 (0) 4 91 29 30 90
Industries & Categories
Health Diagnostics, Medical, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/haliodx-89436 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.